ClinicalTrials.gg
CompletedNCT07287657Updated Oct 21, 2026

Exploring the Effects of Transcutaneous Electrical Acupoint Stimulation Therapy on Patients After Video-Assisted Thoracoscopic Surgery

An interventional study of Standard Analgesia and Transcutaneous Electrical Nerve Stimulation (TENS) in Pain, Postoperative, sponsored by Buddhist Tzu Chi General Hospital. Completed at 1 site in Taiwan. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Buddhist Tzu Chi General Hospital · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled May 2024, registered Apr 2025).
Updated Oct 21, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
15 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 69 studies in Pain, Postoperative with a site in Taiwan — 20 open to participants now, 20 under way, 1 of them phase 3. Pain, Postoperative · Taiwan.

Enrollment
18th of 62
96 · median 71
Started
2024
with 4 others
No phase
38 of 69
14 open now
Registered
61st of 69
by date
Lead sponsor
2 of 69
Buddhist Tzu Chi General Hospital

Among the 69 studies in Pain, Postoperative with a site in Taiwan, this one is the 18th largest by enrollment of the 62 interventional ones that give a count, is one of 5 that started in 2024, is one of 38 with no phase, and was the 61st registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

20 of the 69 studies in Pain, Postoperative with a site in Taiwan are open now. Recruiting first, the newest first:

15 more — sign in →

All 20 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 15 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 69 studies in Pain, Postoperative with a site in Taiwan, or all of them as a file.
02

Study summary

Thoracic surgery is known to be one of the most painful types of surgery. If acute postoperative pain is not properly managed, there is a high risk that it may develop into clinically significant chronic pain within six months after surgery, which can seriously affect quality of life. According to research on Enhanced Recovery After Surgery (ERAS), using multimodal pain management strategies can significantly reduce postoperative pain and decrease reliance on pain medications. This study aims to investigate whether combining transcutaneous Electrical Nerve Stimulation therapy with conventional pain management can further enhance pain relief and improve recovery outcomes.

Read the detailed description

This study aims to evaluate the efficacy of three postoperative analgesic strategies in patients undergoing lesion resection via video-assisted thoracoscopic surgery (VATS). Under standard postoperative care protocols, patients will be randomized into three groups: (1) conventional pharmacologic analgesia alone, (2) conventional analgesia combined with transcutaneous electrical nerve stimulation (TENS), and (3) conventional analgesia combined with both transcutaneous electrical nerve stimulation (TENS) and transcutaneous electrical acupoint stimulation (TEAS). The primary outcomes include the assessment of acute postoperative pain intensity, blood inflammatory biomarkers, health-related quality of life, and the incidence of postoperative complications. This investigation seeks to determine whether adjunctive use of neuromodulatory techniques such as TENS and TEAS can enhance analgesic efficacy and improve postoperative recovery profiles.

03

Conditions studied

  • Pain, Postoperative

Keywords

  • Video-assisted thoracoscopic surgery(VATS)
  • Enhanced Recovery After Surgery(ERAS)
  • pain, postoperative
  • transcutaneous electrical acupoint stimulation
  • transcutaneous electrical nerve stimulation
  • acute pain
  • blood inflammatory biomarkers
  • quality of life
  • Anxiety and Depression
04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • People who are about to undergo thoracic surgery

Exclusion criteria

Exclusion Criteria:

  • Patients with epilepsy,
  • Pacemaker installed
  • Severe infections status
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
96 participants (actual)

Study arms

  • Active comparator
    Control Group

    Participants receive standard postoperative analgesia according to institutional protocol.

    Drug: Standard Analgesia

  • Experimental
    TENS Group

    Participants receive standard postoperative analgesia combined with transcutaneous electrical nerve stimulation (TENS)

    Drug: Standard Analgesia · Device: Transcutaneous Electrical Nerve Stimulation (TENS)

  • Experimental
    TENS + TEAS Group

    Participants receive standard postoperative analgesia combined with both transcutaneous electrical nerve stimulation (TENS) and transcutaneous electrical acupoint stimulation (TEAS).

    Drug: Standard Analgesia · Device: Transcutaneous Electrical Nerve Stimulation (TENS) · Device: Transcutaneous Electrical Acupoint Stimulation (TEAS)

Interventions

  • DrugStandard Analgesia

    Postoperative analgesic medications administered according to standard clinical practice and hospital guidelines

  • DeviceTranscutaneous Electrical Nerve Stimulation (TENS)

    Non-invasive electrical nerve stimulation therapy applied to specific areas to reduce postoperative pain

  • DeviceTranscutaneous Electrical Acupoint Stimulation (TEAS)

    Electrical stimulation applied to specific acupuncture points through the skin to enhance analgesic efficacy and modulate autonomic function.

06

What researchers measure

Primary outcomes

  1. Postoperative Pain Intensity Assessed Using the Visual Analog Scale (VAS)

    Pain intensity will be assessed using a 10-point Visual Analog Scale (VAS), where 0 indicates "no pain" and 10 indicates "worst imaginable pain."

    Time frame: Within 48 hours after surgery

Secondary outcomes

  1. Blood Inflammatory Markers

    Blood inflammatory markers, including the neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR), will be calculated using complete blood count (CBC) parameters. NLR increases are commonly interpreted as indicators of elevated systemic inflammation, whereas decreases in LMR may reflect enhanced inflammatory activity or physiological stress following surgery. These ratios will be assessed at multiple perioperative time points to evaluate changes in inflammatory response. The relationship between postoperative pain levels, clinical recovery, and changes in NLR and LMR will be analyzed to determine whether inflammatory activation is associated with greater postoperative pain or adverse outcomes. Units of measure are expressed as ratios (NLR, LMR).

    Time frame: Within 48 hours after surgery

  2. Hospital Anxiety and Depression Scale

    The Hospital Anxiety and Depression Scale (HADS) will be used to evaluate participants' psychological status during the perioperative period. The scale consists of 14 items, with 7 items assessing anxiety (HADS-A) and 7 items assessing depression (HADS-D). Each item is scored from 0 to 3, yielding subscale scores ranging from 0 to 21. Higher scores indicate greater levels of anxiety or depression. Changes in HADS-A and HADS-D scores will be analyzed to determine postoperative psychological responses and the potential impact of different analgesic interventions.

    Time frame: At baseline (preoperative), and after surgery 6 and 48 hours later

07

Study locations

1 site
  • Hualien Tzu Chi Hospital
    Taipei, Hualien 97002, Taiwan
08

References and documents

Publications

  • Edwards DA, Hedrick TL, Jayaram J, Argoff C, Gulur P, Holubar SD, Gan TJ, Mythen MG, Miller TE, Shaw AD, Thacker JKM, McEvoy MD; POQI-4 Working Group. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Management of Patients on Preoperative Opioid Therapy. Anesth Analg. 2019 Aug;129(2):553-566. doi: 10.1213/ANE.0000000000004018. PubMed 30768461 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided — Because it is still underway, I will share it after the research is completed.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2024 to primary completion in Sep 2025, 16 months.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 16 months is above that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 21, 2026: primary completion Dec 2025 → Sep 2025 and completion Dec 2025 → Sep 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 28, 2025
First posted
Dec 17, 2025
StartActual
May 28, 2024
Primary completionActual
Sep 30, 2025was Dec 2025
CompletionActual
Sep 30, 2025was Dec 2025
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Completed
changed Oct 21, 2026
Primary completion
Dec 31, 2025→Sep 30, 2025 (actual)
Oct 21, 2026
Study completion
Dec 31, 2025→Sep 30, 2025 (actual)
Oct 21, 2026
Enrollment
90 (estimated)→96 (actual)
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    Enrolling by invitation→Completed
    Primary completion Dec 31, 2025→Sep 30, 2025 (now actual)
    Study completion Dec 31, 2025→Sep 30, 2025 (now actual)
    Enrollment 90 (estimated)→96 (actual)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07287657
Lead sponsor
Buddhist Tzu Chi General Hospital
Responsible party
Sponsor
First posted
Dec 17, 2025
Start date
May 28, 2024
Primary completion
Sep 30, 2025
Completion
Sep 30, 2025
Last update
Oct 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion